Ulla Werlauff

842 total citations
41 papers, 381 citations indexed

About

Ulla Werlauff is a scholar working on Genetics, Molecular Biology and Neurology. According to data from OpenAlex, Ulla Werlauff has authored 41 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 18 papers in Molecular Biology and 10 papers in Neurology. Recurrent topics in Ulla Werlauff's work include Neurogenetic and Muscular Disorders Research (19 papers), Muscle Physiology and Disorders (15 papers) and Genetic Neurodegenerative Diseases (6 papers). Ulla Werlauff is often cited by papers focused on Neurogenetic and Muscular Disorders Research (19 papers), Muscle Physiology and Disorders (15 papers) and Genetic Neurodegenerative Diseases (6 papers). Ulla Werlauff collaborates with scholars based in Denmark, South Korea and Sweden. Ulla Werlauff's co-authors include Birgit F. Steffensen, John Vissing, Nanna Witting, Morten Dunø, Charlotte Handberg, Mogens Erlandsen, Anna‐Karin Kroksmark, Jes Rahbek, Thomas Sejersen and Tina Duong and has published in prestigious journals such as PLoS ONE, Quality of Life Research and Developmental Medicine & Child Neurology.

In The Last Decade

Ulla Werlauff

35 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulla Werlauff Denmark 12 189 185 73 68 56 41 381
Jes Rahbek Denmark 12 298 1.6× 247 1.3× 81 1.1× 55 0.8× 100 1.8× 24 606
Maria Kinali United Kingdom 14 280 1.5× 244 1.3× 142 1.9× 36 0.5× 34 0.6× 20 584
Joyce Oleszek United States 12 163 0.9× 84 0.5× 98 1.3× 80 1.2× 30 0.5× 29 450
Simone Thiele Germany 11 340 1.8× 326 1.8× 186 2.5× 46 0.7× 46 0.8× 31 637
Christina Trout United States 9 309 1.6× 110 0.6× 24 0.3× 74 1.1× 66 1.2× 13 441
Simona Lucibello Italy 16 287 1.5× 300 1.6× 231 3.2× 38 0.6× 52 0.9× 28 610
K. Bushby United Kingdom 7 397 2.1× 183 1.0× 32 0.4× 82 1.2× 104 1.9× 13 652
Soman Puzhankara United States 8 390 2.1× 132 0.7× 68 0.9× 110 1.6× 107 1.9× 12 589
Maria Bernadete Dutra de Resende Brazil 12 246 1.3× 84 0.5× 35 0.5× 40 0.6× 49 0.9× 23 326
Christina Westfield United States 10 308 1.6× 112 0.6× 24 0.3× 72 1.1× 62 1.1× 19 388

Countries citing papers authored by Ulla Werlauff

Since Specialization
Citations

This map shows the geographic impact of Ulla Werlauff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulla Werlauff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulla Werlauff more than expected).

Fields of papers citing papers by Ulla Werlauff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulla Werlauff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulla Werlauff. The network helps show where Ulla Werlauff may publish in the future.

Co-authorship network of co-authors of Ulla Werlauff

This figure shows the co-authorship network connecting the top 25 collaborators of Ulla Werlauff. A scholar is included among the top collaborators of Ulla Werlauff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulla Werlauff. Ulla Werlauff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Werlauff, Ulla, Henning Andersen, John Vissing, et al.. (2025). Multiorgan Involvement and Mortality in Individuals With Adult‐Onset Myotonic Dystrophy (DM1)—A Danish Register‐Based Study I. European Journal of Neurology. 32(4). e70135–e70135. 3 indexed citations
2.
Handberg, Charlotte, Henning Andersen, John Vissing, et al.. (2025). Societal Costs, Healthcare Utilisation and Labour Market Affiliation of Persons With Adult‐Onset Myotonic Dystrophy Type 1 (DM1)—A Register‐Based Study II. European Journal of Neurology. 32(6). e70211–e70211.
3.
Handberg, Charlotte, et al.. (2025). Challenges and rehabilitation needs among adults with myasthenia gravis – a Danish cross-sectional questionnaire study. Disability and Rehabilitation. 48(3). 701–709. 1 indexed citations
4.
Dreyer, Pia, et al.. (2024). Living with adult-onset myotonic dystrophy type 1: a scoping review. Disability and Rehabilitation. 47(9). 2246–2257. 4 indexed citations
5.
Vissing, John, Ulla Werlauff, Charlotte Olesen, et al.. (2024). Burden of Disease of Duchenne Muscular Dystrophy in Denmark – A National Register-Based Study of Individuals with Duchenne Muscular Dystrophy and their Closest Relatives. Journal of Neuromuscular Diseases. 11(2). 443–457. 1 indexed citations
6.
Young, Sally Dunaway, Katlyn McGrattan, Emily Johnson, et al.. (2023). Development of an International SMA Bulbar Assessment for Inter-professional Administration. Journal of Neuromuscular Diseases. 10(4). 639–652. 7 indexed citations
7.
8.
9.
Martinsen, Bente, et al.. (2021). Ageing with neuromuscular disease: getting lost in transitions. Disability and Rehabilitation. 44(16). 4311–4318. 5 indexed citations
10.
Beernaert, Kim, Malin Lövgren, Jørgen Jeppesen, et al.. (2019). Parents’ Experiences of Information and Decision Making in the Care of Their Child With Severe Spinal Muscular Atrophy: A Population Survey. Journal of Child Neurology. 34(4). 210–215. 17 indexed citations
11.
Klingels, Katrijn, Tina Duong, V. Decostre, et al.. (2016). Development of a patient‐reported outcome measure for upper limb function in Duchenne muscular dystrophy: DMD Upper Limb PROM. Developmental Medicine & Child Neurology. 59(2). 224–231. 33 indexed citations
12.
Werlauff, Ulla, Helle Petri, Nanna Witting, & John Vissing. (2015). Frequency and Phenotype of Myotubular Myopathy Amongst Danish Patients with Congenital Myopathy Older than 5 Years. Journal of Neuromuscular Diseases. 2(2). 167–174. 9 indexed citations
13.
Witting, Nanna, et al.. (2014). Frequency and phenotype of patients carrying TPM2 and TPM3 gene mutations in a cohort of 94 patients with congenital myopathy. Neuromuscular Disorders. 24(4). 325–330. 11 indexed citations
14.
Werlauff, Ulla & Birgit F. Steffensen. (2014). The applicability of four clinical methods to evaluate arm and hand function in all stages of spinal muscular atrophy type II. Disability and Rehabilitation. 36(25). 2120–2126. 15 indexed citations
15.
Werlauff, Ulla, et al.. (2013). Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale. Quality of Life Research. 23(5). 1479–1488. 34 indexed citations
16.
Werlauff, Ulla, John Vissing, & Birgit F. Steffensen. (2012). Change in muscle strength over time in spinal muscular atrophy types II and III. A long-term follow-up study. Neuromuscular Disorders. 22(12). 1069–1074. 26 indexed citations
17.
Werlauff, Ulla, et al.. (2009). Physical characteristics and applicability of standard assessment methods in a total population of spinal muscular atrophy type II patients. Neuromuscular Disorders. 20(1). 34–43. 17 indexed citations
18.
Mayhew, Anna, A. Aloysius, Sonia Messina, et al.. (2008). Egen classification revisited in SMA. UCL Discovery (University College London). 1 indexed citations
19.
Steffensen, Birgit F., et al.. (2001). Longitudinal data analysis: an application to construction of a natural history profile of Duchenne muscular dystrophy. Neuromuscular Disorders. 11(2). 165–170. 14 indexed citations
20.
Kroksmark, Anna‐Karin, et al.. (2000). A randomized comparative study of two methods for controlling Tendo Achilles contracture in Duchenne muscular dystrophy. Neuromuscular Disorders. 10(4-5). 257–263. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jes Rahbek Breakdown of academic impact, for papers by Maria Kinali Breakdown of academic impact, for papers by Joyce Oleszek Breakdown of academic impact, for papers by Simone Thiele Breakdown of academic impact, for papers by Christina Trout Breakdown of academic impact, for papers by Simona Lucibello Breakdown of academic impact, for papers by K. Bushby Breakdown of academic impact, for papers by Soman Puzhankara Breakdown of academic impact, for papers by Maria Bernadete Dutra de Resende Breakdown of academic impact, for papers by Christina Westfield
Rankless by CCL
2026